Stories indexed under: Wisconsin Alumni Research Foundation

Total: 48   RSSRSS feed

  • Registration now open for Wisconsin Science and Technology Symposium July 2, 2009 The second annual Wisconsin Science and Technology Symposium, to be held July 23 and 24, will bring together science and technology researchers, entrepreneurs, and investors from across the state to help them share ideas and spark new collaborations.
  • Cellectar shares inventor, investor and CEO perspectives at WARF Gilson Series June 18, 2009 The perspectives of the inventor, investor and CEO of Madison's rising startup radiopharmaceutical company Cellectar Inc. will be the focus of the Wisconsin Alumni Research Foundation's Gilson Discovery Series event, to be held at 5 p.m. on Wednesday, June 24, at the Fluno Center, 601 University Ave.
  • WARF signs license agreement with Pfizer for human embryonic stem cells May 6, 2009 Pfizer Inc., a major biopharmaceutical company, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced May 5 that they have signed a license for human embryonic stem (hES) cell patents for the development of new drug therapies.
  • Sustainability to be focus of annual bioethics forum April 20, 2009 Sustainability will be the focus of the eighth annual International Bioethics Forum to be held in Madison Thursday and Friday, April 23 and 24.
  • Still from video Researchers use brain interface to post to Twitter April 20, 2009 In early April, Adam Wilson posted a status update on the social networking Web site Twitter - just by thinking about it.
  • Biotech pioneer presents ‘From Research to Commercial Reality, in the New World’ March 2, 2009 Famed chemist, biotech pioneer and Harvard University professor George M. Whitesides will present "From Research to Commercial Reality, in the New World" at 5 p.m. on Monday, March 9, at the Fluno Center, 601 University Ave.
  • Genetic information personalizes warfarin prescribing Feb. 18, 2009 Warfarin, one of the world's most widely used drugs, is also one of the trickiest to prescribe. Half of those who take it are at risk of serious problems when given the standard starting dose.
  • Cellartis, WARF sign license agreement for human embryonic stem cells Jan. 15, 2009 Cellartis AB, a premier provider of human embryonic stem cell (hES) derived products and technologies, and the Wisconsin Alumni Research Foundation (WARF), the private, nonprofit patenting and licensing organization for the University of Wisconsin-Madison, announced today (Jan. 15) that they have signed a license for hES patents that enables Cellartis to commercialize undifferentiated hES cell products in the U.S.